[HTML][HTML] Enhancing HepG2 cell apoptosis with a combined nanoparticle delivery of miR-128-3p agomir and Oroxin B: A novel drug delivery approach based on PI3K …
H Wang, X Shen, X Zhu, S Zeng, S Cai - Asian Journal of Pharmaceutical …, 2024 - Elsevier
Hepatocellular carcinoma (HCC) shows the highest morbidity among liver cancers and
accounts for a major factor inducing cancer-associated mortality globally. It is characterized …
accounts for a major factor inducing cancer-associated mortality globally. It is characterized …
Cationic graphene oxide nanoplatform mediates miR-101 delivery to promote apoptosis by regulating autophagy and stress
Introduction MicroRNA-101 (miR-101) is an intense cancer suppressor with special
algorithm to target a wide range of pathways and genes which indicates the ability to …
algorithm to target a wide range of pathways and genes which indicates the ability to …
Targeted delivery of glypican 3 (GPC3) antibody-modified microRNA (miR let-7b-5p) polymer nanoparticles to sorafenib-resistant hepatsocellular carcinoma cells
S Zhou, Y Ma, X Liu, P Yu, N Huang… - Journal of …, 2021 - ingentaconnect.com
The miR let-7b-5p (a kind of microRNAs) has many pathophysiological regulation effects,
including human hepatocellular carcinoma (HCC) pathogenesis. This study investigated …
including human hepatocellular carcinoma (HCC) pathogenesis. This study investigated …
[PDF][PDF] RETRACTED ARTICLE: miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a …
F Li, F Wang, C Zhu, Q Wei, T Zhang… - International journal of …, 2018 - Taylor & Francis
Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL. Int J Nanomedicine. 2018; 13: 2295–2307.
The Editor and Publisher of International Journal of Nanomedicine wish to retract the …
The Editor and Publisher of International Journal of Nanomedicine wish to retract the …
MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1
X Zhao, Y Jin, L Li, L Xu, Z Tang, Y Qi, L Yin… - Pharmacological …, 2019 - Elsevier
As one classic anticancer drug, clinical application of Doxorubicin (Dox) is limited due to its
side effects. In our previous work, we have investigated the drug targets to treat Dox-induced …
side effects. In our previous work, we have investigated the drug targets to treat Dox-induced …
Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with high mortality,
poor prognosis, and palliative treatments, due to the rapid upregulation of alternative …
poor prognosis, and palliative treatments, due to the rapid upregulation of alternative …
Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis
Liver metastasis is a leading cause of cancer morbidity and mortality. Thus, there has been
strong interest in the development of therapeutics that can effectively prevent liver …
strong interest in the development of therapeutics that can effectively prevent liver …
Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy
Y Ren, R Wang, L Gao, K Li, X Zhou, H Guo… - Journal of Controlled …, 2016 - Elsevier
Previous literature and our study showed the delivery sequence of microRNA inhibitor and
chemotherapeutic compounds achieve distinct therapeutic anticancer efficacy. Yet, it is …
chemotherapeutic compounds achieve distinct therapeutic anticancer efficacy. Yet, it is …
Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2/p38 signaling pathway in vitro and in vivo
L Liu, L Wang, X Li, P Tian, H Xu, Z Li… - … cells, nanomedicine, and …, 2019 - Taylor & Francis
The objective of this study was to investigate the mechanism underlying miR-21-associated
apoptosis in HB. In this study, HB and adjacent tissues were collected from patients with HB …
apoptosis in HB. In this study, HB and adjacent tissues were collected from patients with HB …
Retracted Article: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
S Yang, Z Chen, D Fan, R Zhang, Y Zhang, S Wu - RSC advances, 2018 - pubs.rsc.org
We investigated whether miR-182-5p or miR-96-5p could increase hepatocellular
carcinoma (HCC) development by targeting Rho Family GTPase 3 (RND3) gene expression …
carcinoma (HCC) development by targeting Rho Family GTPase 3 (RND3) gene expression …